Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2014
Total Assets: $2.33B
Liabilities Breakdown FY2014
Total Liabilities: $1.24B
Asset Breakdown
Total Assets: $2.33B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $625.3M | 26.8% |
| Accounts Receivable | $76.0M | 3.3% |
| Inventory | $30.8M | 1.3% |
| Property, Plant & Equipment | $715.8M | 30.7% |
| Goodwill | $39.9M | 1.7% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $846.9M | 36.3% |
Liabilities Breakdown
Total Liabilities: $1.24B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $71.2M | 5.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.17B | 94.3% |